Physician profile
Jacobo Leon
NPI 1972863629
$523.03
in general payments reported to CMS, 2019-2025
9 companies · $237 in 2025
The $237 reported for 2025 was more than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $18.87 · 2022: $16.24 · 2023: $156 · 2024: $94.81 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $487.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $239.45 | 2023-2025 | Zerbaxa, Dificid, Recarbrio |
| Viiv Healthcare Company | $62.81 | 2020-2025 | Dovato |
| Abbvie INC. | $48.47 | 2024 | |
| Shionogi INC | $47.82 | 2023-2025 | Fetroja |
| La Jolla Pharmaceutical Company | $40.51 | 2025 | Xacduro, Zevtera |
| Melinta Therapeutics, LLC | $32.20 | 2025 | Rezzayo, Orbactiv, Kimyrsa |
| Convatec INC. | $21.44 | 2024 | |
| Insmed, INC. | $16.24 | 2022 | |
| Emd Serono, INC. | $14.09 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacobo Leon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.